Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

11 structures for Q9Y3C1

Entry ID Method Resolution Chain Position Source
8FKP EM 285 A SZ 1-178 PDB
8FKQ EM 276 A SZ 1-178 PDB
8FKR EM 289 A SZ 1-178 PDB
8FKS EM 288 A SZ 1-178 PDB
8FKT EM 281 A SZ 1-178 PDB
8FKU EM 282 A SZ 1-178 PDB
8FKV EM 247 A SZ 1-178 PDB
8FKW EM 250 A SZ 1-178 PDB
8FKX EM 259 A SZ 1-178 PDB
8FKY EM 267 A SZ 1-178 PDB
AF-Q9Y3C1-F1 Predicted AlphaFoldDB

152 variants for Q9Y3C1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs768676655
CA3568533
2 P>L No ClinGen
ExAC
gnomAD
CA3568530
rs749169901
3 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs777430631
CA3568528
4 A>T No ClinGen
ExAC
gnomAD
rs756120217
CA3568527
5 K>E No ClinGen
ExAC
gnomAD
rs371311461
CA131872955
6 G>D No ClinGen
ESP
TOPMed
gnomAD
TCGA novel 8 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1359686985
CA362255835
9 R>W No ClinGen
gnomAD
CA362255804
rs1222357596
11 Q>* No ClinGen
gnomAD
CA362255806
rs1222357596
11 Q>E No ClinGen
gnomAD
CA362255808
rs1222357596
11 Q>K No ClinGen
gnomAD
rs1026225217
CA131872941
12 K>N No ClinGen
TOPMed
rs201660459
CA3568524
17 V>D No ClinGen
1000Genomes
ExAC
gnomAD
rs751258265
CA3568523
18 N>H No ClinGen
ExAC
gnomAD
CA3568522
rs765994335
18 N>S No ClinGen
ExAC
gnomAD
CA3568520
rs374285141
24 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3568518
rs762354832
27 R>G No ClinGen
ExAC
CA362255655
rs1417035183
28 R>W No ClinGen
TOPMed
gnomAD
TCGA novel 30 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768728192
CA3568516
32 P>R No ClinGen
ExAC
gnomAD
CA3568514
rs775419543
33 R>P No ClinGen
ExAC
gnomAD
rs772408909
CA3568513
35 E>D No ClinGen
ExAC
gnomAD
rs1340496823
CA362255145
39 I>V No ClinGen
gnomAD
CA3568497
rs35906642
40 R>G No ClinGen
ExAC
gnomAD
CA131872669
rs369167277
43 W>* No ClinGen
ESP
TOPMed
rs772025977
CA3568496
44 D>H No ClinGen
ExAC
TOPMed
CA362255073
rs772025977
44 D>N No ClinGen
ExAC
TOPMed
rs759828112
CA3568495
45 H>Q No ClinGen
ExAC
gnomAD
CA131872648
rs200947536
46 A>T No ClinGen
Ensembl
CA3568494
rs761435181
48 S>* No ClinGen
ExAC
TOPMed
gnomAD
rs769713350
CA3568493
49 V>A No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 50 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201019782
CA3568492
51 Q>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1470225702
CA362254944
54 A>P No ClinGen
gnomAD
rs768780614
CA3568490
59 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA362254876
rs1167631598
62 P>S No ClinGen
gnomAD
CA362254855
rs369903036
64 R>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369903036
CA3568489
64 R>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3568488
rs376625530
65 A>V No ClinGen
ESP
ExAC
gnomAD
CA362254840
rs1350415891
66 V>E No ClinGen
gnomAD
CA3568486
rs750097354
68 L>F No ClinGen
ExAC
gnomAD
rs1204787616
CA362254823
68 L>H No ClinGen
TOPMed
gnomAD
CA3568487
rs750097354
68 L>V No ClinGen
ExAC
gnomAD
rs1260922329
CA362254819
69 R>C No ClinGen
TOPMed
rs372260739
CA362254818
69 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372260739
CA3568485
69 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs372260739
CA362254817
69 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA362254812
rs1484739968
70 K>R No ClinGen
TOPMed
rs754267917
CA3568483
71 R>G No ClinGen
ExAC
gnomAD
rs760330393
CA3568450
73 V>G No ClinGen
ExAC
gnomAD
CA362254781
rs1271852355
73 V>M No ClinGen
TOPMed
rs1011453221
CA362254771
74 K>N No ClinGen
gnomAD
rs771970692
CA3568448
75 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs775343536
CA3568449
75 A>T No ClinGen
ExAC
gnomAD
CA362254766
rs771970692
75 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA362254746
rs1271196300
78 V>L No ClinGen
TOPMed
rs770383955
CA3568445
80 I>K No ClinGen
ExAC
TOPMed
gnomAD
CA3568443
rs777343793
81 E>A No ClinGen
ExAC
gnomAD
rs748973633
CA3568444
81 E>K No ClinGen
ExAC
gnomAD
CA362254722
rs1398857598
82 E>* No ClinGen
Ensembl
CA3568442
rs756512349
83 R>G No ClinGen
ExAC
gnomAD
CA131871264
rs748516531
83 R>K No ClinGen
ExAC
TOPMed
gnomAD
rs748516531
CA3568441
83 R>T No ClinGen
ExAC
TOPMed
gnomAD
rs1227260064
CA362254703
85 K>E No ClinGen
gnomAD
rs1227260064
CA362254704
85 K>Q No ClinGen
gnomAD
CA3568440
rs781612471
88 V>I No ClinGen
ExAC
gnomAD
CA362254675
rs1429153685
89 R>Q No ClinGen
TOPMed
gnomAD
CA362254676
rs752090377
89 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 92 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3568437
rs780301628
94 L>P No ClinGen
ExAC
TOPMed
gnomAD
CA362254421
rs1310965446
98 E>D No ClinGen
TOPMed
gnomAD
CA3568404
rs761394555
98 E>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 99 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3568403
rs776304308
100 E>* No ClinGen
ExAC
TOPMed
gnomAD
CA362254414
rs776304308
100 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA362254402
rs1215551465
101 A>G No ClinGen
gnomAD
rs1013152581
CA362254367
106 K>N No ClinGen
TOPMed
gnomAD
CA362254339
rs1561781742
110 T>S No ClinGen
Ensembl
TCGA novel 112 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768904952
CA362254324
113 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs768904952
CA3568401
113 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA362254325
rs1468526131
113 R>W Variant assessed as Somatic; 4.638e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs747437624
CA3568400
114 D>G No ClinGen
ExAC
gnomAD
rs780563268
CA3568399
116 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA362254307
rs1490053833
116 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3568398
rs772746797
118 Y>C No ClinGen
ExAC
CA362254288
rs1321988014
119 V>I No ClinGen
gnomAD
rs35916027
CA3568397
120 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3568396
rs778885926
120 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs550414913
CA131870401
122 M>L No ClinGen
1000Genomes
rs757323676
CA3568395
124 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs749478336
CA3568394
125 N>T No ClinGen
ExAC
gnomAD
rs777997362
CA3568393
126 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA3568390
CA3568391
rs766126221
127 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 128 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA362254217
rs1332944885
129 D>E No ClinGen
TOPMed
rs564105798
CA3568387
130 Y>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs531236625
CA3568389
130 Y>N No ClinGen
1000Genomes
ExAC
gnomAD
rs564105798
CA3568388
130 Y>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1292266651
CA362253889
132 A>D No ClinGen
TOPMed
rs752413462
CA3568341
134 A>T No ClinGen
ExAC
gnomAD
CA3568340
rs767341425
134 A>V No ClinGen
ExAC
gnomAD
rs759109610
CA3568339
135 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3568338
rs751991573
135 R>H No ClinGen
ExAC
gnomAD
rs201464061
CA3568337
136 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1332463491
CA362253833
136 D>Y No ClinGen
TOPMed
rs1167787140
CA362253793
138 K>N No ClinGen
gnomAD
rs763535412
CA3568336
139 N>Y No ClinGen
ExAC
gnomAD
rs1443198030
CA362253755
141 Y>C No ClinGen
gnomAD
CA3568333
rs769866161
142 Q>* No ClinGen
ExAC
gnomAD
rs1201501127
CA362253738
142 Q>H No ClinGen
gnomAD
rs11556383
CA131869663
142 Q>P No ClinGen
TOPMed
CA362253727
rs1480617288
143 D>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs761822995
CA3568332
144 T>N No ClinGen
ExAC
gnomAD
rs768963656
CA3568330
146 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA362253669
rs1187168709
147 Q>R No ClinGen
TOPMed
rs1255635175
CA362253653
148 I>M No ClinGen
TOPMed
rs747177509
CA3568329
148 I>T No ClinGen
ExAC
gnomAD
CA3568328
rs778792802
149 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA131869629
rs200749495
149 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
NCI-TCGA
TOPMed
gnomAD
CA362253607
rs1314670444
152 I>M No ClinGen
gnomAD
CA131869624
rs994865659
154 V>I No ClinGen
TOPMed
gnomAD
CA362253587
rs1431107056
155 Y>C No ClinGen
TOPMed
gnomAD
CA3568325
rs374004308
155 Y>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3568326
rs374004308
155 Y>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 156 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3568323
rs369844270
157 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs535942388
CA3568322
157 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3568324
rs369844270
157 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1442444633
CA362253565
158 F>V No ClinGen
gnomAD
CA131869573
rs967264894
159 Y>C No ClinGen
TOPMed
TCGA novel 159 Y>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3568321
rs751121017
160 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs751121017
CA3568320
160 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1418994963
CA362253543
161 A>P No ClinGen
gnomAD
rs1581403349
CA362253532
162 E>A No ClinGen
Ensembl
CA131869542
rs987270358
163 W>* No ClinGen
TOPMed
gnomAD
CA3568316
rs765792065
165 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA3568317
rs750939447
165 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs781413892
CA131869526
167 L>F No ClinGen
TOPMed
gnomAD
rs776742412
CA3568314
168 D>N No ClinGen
ExAC
gnomAD
rs764031980
CA3568313
169 S>Y No ClinGen
ExAC
TOPMed
gnomAD
rs574974181
CA3568312
170 L>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs775509663
CA3568311
171 Q>H No ClinGen
ExAC
gnomAD
CA3568310
rs556727834
172 K>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs144915498
CA3568309
173 R>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3568308
rs570834002
174 K>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769896171
CA3568307
175 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs374069039
CA131869445
175 M>V No ClinGen
ESP
CA3568306
rs748073250
176 E>D No ClinGen
ExAC
rs1561780115
CA362253413
177 V>G No ClinGen
Ensembl
TCGA novel 178 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1477959866
CA362253407
178 E>K No ClinGen
TOPMed

No associated diseases with Q9Y3C1

No regional properties for Q9Y3C1

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q9Y3C1

Functions

Description
EC Number
Subcellular Localization
  • Nucleus, nucleolus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

1 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.

1 GO annotations of biological process

Name Definition
ribosomal large subunit biogenesis A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MPKAKGKTRR QKFGYSVNRK RLNRNARRKA APRIECSHIR HAWDHAKSVR QNLAEMGLAV
70 80 90 100 110 120
DPNRAVPLRK RKVKAMEVDI EERPKELVRK PYVLNDLEAE ASLPEKKGNT LSRDLIDYVR
130 140 150 160 170
YMVENHGEDY KAMARDEKNY YQDTPKQIRS KINVYKRFYP AEWQDFLDSL QKRKMEVE